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The emergence of resistance is a preoccupant health threat and the development of new strategies and the 
use of novel compounds are in demand. Specifically, biofilm infections are a serious threat, causing chronic, 
nosocomial and biomaterial related infections, being related to dissemination of antibiotic resistance. 
Pseudomonas aeruginosa and Staphylococcus aureus are great developers of resistance and their ability to 
form biofilms makes them responsible for severe chronic infections. In this work, we associated the use of 
novel compounds – antimicrobial peptides (AMPs) – with a combination strategy. The AMP/antibiotic 
colistin was combined with three other AMPs (linear tachyplesin I; temporin A; citropin 1.1). Previous 
results showed the ability of these AMPs to combine synergistically against these bacteria. Here, we test 
these combinations against single pre-established biofilms and the results show promise. Currently, we are 
testing these combinations on mixed biofilms to assess their use in polymicrobial infections.  
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The accumulation of reactive oxygen species (ROS) in microbial biofilms has been recently recognized to 
play a role in promoting antibiotic resistance in biofilm-growing bacteria. An over- production of ROS is 
also induced after implantation of a medical device as a consequence of the natural foreign body-reaction. 
This phenomenon is known not only to promote the oxidative degradation of the device itself but also to 
increase device susceptibility to infection or aseptic loosening. In this study, a novel antioxidant polymer 
based on hydroxytyrosol was synthesized. Hydroxytyrosol (HTy) is a natural polyphenolic compound that 
can be extracted from olive oil wastewaters. This compound, besides possessing a strong antioxidant 
activity, has been shown to have antimicrobial activity against some gram-positive species including 
Staphylococcus epidermidis and Staphylococcus aureus. A polymer bearing HTy in side-chain was 
successfully obtained by performing a simple radical polymerization. This polymer showed a significant free 
radical scavenging activity and also a good antimicrobial activity against a standard strain of S. epidermidis, 
with a minimum inhibitory concentration of 2.5 mg/mL. These preliminary, promising findings prompted us 
to plan further investigations to evaluate the role of this new polymer in suppressing the oxidative stress in 
biofilm communities and preventing medical device-related infections. 
  
